These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyroid disorders induced by checkpoint inhibitors. Ferrari SM; Fallahi P; Galetta F; Citi E; Benvenga S; Antonelli A Rev Endocr Metab Disord; 2018 Dec; 19(4):325-333. PubMed ID: 30242549 [TBL] [Abstract][Full Text] [Related]
3. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. Barroso-Sousa R; Barry WT; Garrido-Castro AC; Hodi FS; Min L; Krop IE; Tolaney SM JAMA Oncol; 2018 Feb; 4(2):173-182. PubMed ID: 28973656 [TBL] [Abstract][Full Text] [Related]
4. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. Chang LS; Barroso-Sousa R; Tolaney SM; Hodi FS; Kaiser UB; Min L Endocr Rev; 2019 Feb; 40(1):17-65. PubMed ID: 30184160 [TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitors-Induced Endocrinopathies: Assessment, Management and Monitoring in a Comprehensive Cancer Centre. Elshafie O; Khalil AB; Salman B; Atabani A; Al-Sayegh H Endocrinol Diabetes Metab; 2024 Jul; 7(4):e00505. PubMed ID: 38932429 [TBL] [Abstract][Full Text] [Related]
6. How we treat endocrine complications of immune checkpoint inhibitors. Paschou SA; Stefanaki K; Psaltopoulou T; Liontos M; Koutsoukos K; Zagouri F; Lambrinoudaki I; Dimopoulos MA ESMO Open; 2021 Feb; 6(1):100011. PubMed ID: 33399077 [TBL] [Abstract][Full Text] [Related]
8. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system. Zhai Y; Ye X; Hu F; Xu J; Guo X; Zhuang Y; He J J Immunother Cancer; 2019 Nov; 7(1):286. PubMed ID: 31694698 [TBL] [Abstract][Full Text] [Related]
9. New insight in endocrine-related adverse events associated to immune checkpoint blockade. Elia G; Ferrari SM; Galdiero MR; Ragusa F; Paparo SR; Ruffilli I; Varricchi G; Fallahi P; Antonelli A Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101370. PubMed ID: 31983543 [TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitor-related hypophysitis. Mizukoshi T; Fukuoka H; Takahashi Y Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101668. PubMed ID: 35562229 [TBL] [Abstract][Full Text] [Related]
11. Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Bai X; Lin X; Zheng K; Chen X; Wu X; Huang Y; Zhuang Y Endocrine; 2020 Sep; 69(3):670-681. PubMed ID: 32507965 [TBL] [Abstract][Full Text] [Related]
12. The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma. Scott ES; Long GV; Guminski A; Clifton-Bligh RJ; Menzies AM; Tsang VH Eur J Endocrinol; 2018 Feb; 178(2):173-180. PubMed ID: 29187509 [TBL] [Abstract][Full Text] [Related]
13. [Endocrinopathies induced by immune checkpoint inhibitors]. Jaafar J; Mavromati M; Philippe J Rev Med Suisse; 2018 Jan; 14(588-589):34-38. PubMed ID: 29337446 [TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint inhibitors and endocrine side effects, a narrative review. Agrawal L; Bacal A; Jain S; Singh V; Emanuele N; Emanuele M; Meah F Postgrad Med; 2020 Mar; 132(2):206-214. PubMed ID: 31876444 [TBL] [Abstract][Full Text] [Related]
15. Endocrine side effects induced by immune checkpoint inhibitors. Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977 [TBL] [Abstract][Full Text] [Related]
16. The side effects of immune checkpoint inhibitor therapy on the endocrine system. Goyal I; Pandey MR; Sharma R; Chaudhuri A; Dandona P Indian J Med Res; 2021 Apr; 154(4):559-570. PubMed ID: 35435341 [TBL] [Abstract][Full Text] [Related]